PTD2 TFA
Référence T83850-100mg
Conditionnement : 100mg
Marque : TargetMol
Product Information
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | PTD2, derived from the histone 4 sequence, acts as a peptide inhibitor against Wolf-Hirschhorn syndrome candidate 1 (WHSC1; IC50 = 22 µM), a histone methyltransferase. |
| Molecular Weight | 597.80 |
| Formula | C27H51N9O6.XCF3COOH |
| Smiles | NC([C@@]([C@H](CC)C)(22)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](C(C)C)NC(CNC(C)=O)=O)=O)CCCC)=O)=O)=O.OC(C(F)(F)F)=O |
| Sequence | Ac-Gly-Val-Nle-Arg-Ile-NH₂ |
| Sequence Short | GVXRI |
| Storage | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | PBS pH 7.2: 1 mg/mL (1.67 mM), Sonication is recommended. DMSO: 10 mg/mL (16.73 mM), Sonication is recommended. DMF: 2 mg/m, Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
PBS pH 7.2/DMSO
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||


